With all the talk of low float, many outstanding shorts, and final approval for Zecuity as the first and only FDA-approved migraine patch, and the stock closes LOWER than it did the day before! This defies fundamental financial logic! I guess investors here have to hold their shares for an announcement indicating partnership with a large pharmecutical company....
I don't get it at all. I invested heavily for me anyways which is 5 grand and i just don't understand. I wonder if it didn't get approved would it have stayed at same price as well? Looks like this was all 100% risk with no chance of reward
Something is not right, with current share price the market capacity is at 65 Million. However, the market capacity of Zecuity is conservatively around 200-300 Million, which is 3 times more than the current share price. The share price should be around 9-10, but the market thinks otherwise.
The answer is that most PATH investors were in it on a short term basis (like me) and were just playing the approval which was apparently already baked into the price. I sold 22,500 shares for a $.55/share profit. Wish I had dumped on the open, but still did ok. I think PATH will probably do well over the next few months, but you'll have to wait a while.